We’re untangling an emerging phenomenon: that a high valuation can sometimes be a detriment, rather than an asset, when it comes to recruiting key AI talent.
DekaBank Deutsche Girozentrale decreased its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 70.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 3,843 shares of the company’s stock after selling 9,191 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Zymeworks were worth $40,000 as […]
Form DEFA14A Eliem Therapeutics, Inc. streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Leap Therapeutics (LPTX) Prices 12.66M Share Private Placement at $2.82/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.